Together, they focus on a shared goal:

Creating a world without cancer.


Funding Opportunities:
External Funding Opportunities

National Institutes of Health / National Cancer Institute



Funding Opportunity


NIH Funding Opportunities


Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) 

August 31, 2018

NIH Time-Sensitive Obesity Policy and Program Evaluation (R01) 


September 13, 2018

NIH Director’s Pioneer Award (DP1)

September 14, 2018

NIH Improving the Reach and Quality of Cancer Care in Rural Populations (R01)

September 19, 2018

NIH Diet and Physical Activity Assessment Methodology 

       R01  Deadline:  October 5

       R21  Deadline:  October 16


NIH Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival 

       R01  Deadline:  October 5

      R21  Deadline:  October 16


NIH Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)


October 5, 2018

NIH Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01) 


October 5, 2018

NIH Advancing Extracellular RNA (exRNA) Communication Research: Towards Single Extracellular Vesicle (EV) Sorting, Isolation, and Analysis of Cargo (UG3/UH3) 

October 23, 2018

NIH Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3) 


October 23, 2018

NIH Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research  The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations. 

  • R01  Deadline:  October 24
  • R21  Deadline:  October 24

October 24, 2018

NIH Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects  The purpose of this funding opportunity announcement is to support basic research examining how Electronic Nicotine Delivery Systems (ENDS) aerosols affect normal and disease states relevant to human cells, tissues and organs.

  • R01  Deadline:  October 24
  • R21  Deadline:  October 24

October 24, 2018

NIH Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01) 

October 29, 2018

NIH Innovative Adaptations to Simplify Existing Technologies for Manipulation and Analysis of Glycans (U01) 


October 29, 2018

NIH-NCI Outstanding Investigator Award (R35) 


November 2, 2018

NIH The Role of Epitranscriptomics in Development and Disease  The purpose of this FOA is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA.  Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease.  Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known.  The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the participating ICs.

         R01  Deadline:  November 7

         R21  Deadline:  November 7

November 7, 2018

NIH Modular R01s in Cancer Control and Population Sciences (R01)

November 7, 2018

NIH Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) 

November 19, 2018

NIH Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33)   

November 27, 2018

NIH Pediatric Immunotherapy Discovery and Development Network (PI-DDN)

        U01  Deadline: December 17

        U54 Deadline: December 17


NIH Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) 

January 9, 2019

NIH-NCI Research Specialist (Laboratory-based Scientist) Award (R50) 

January 11, 2019

NIH-NCI Research Specialist (Core-based Scientist) Award (R50) 

January 11, 2019

NIH Notice of Intent to Publish a FOA for Diversity Program Consortium Dissemination and Translation Awards (U01)

July 1, 2020

NIH Administrative Supplements to Existing NIH Grants and Cooperative Agreements.  The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted. 


Varies by awarding IC




Funding Opportunity


DOD-CDMRP Kidney Cancer Research ProgramThe KCRP’s vision is to eliminate kidney cancer through collaboration and discovery. The KCRP’s mission is to promote rigorous, innovative, high-impact research in kidney cancer for the benefit of Service members, Veterans, and the American public.  Mechanisms include:  Physician Research Award, Technology Development Award, Translational Research Partnership Award, Concept Award, and Idea Development Award 

Deadlines:  September 5 – Pre-application; September 26 - Application


DOD-CDMRP Prostate Cancer  The PCRP seeks to promote: highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; the next generation of prostate cancer investigators through mentored research; and resources that will facilitate translational research. Four mechanisms were previously announced and this posting reflects two new mechanisms including:  Health Disparity Research Award and Health Disparity Fellowship Award. 

Deadline:  September 20 – Pre-application; October 11 – Application

NSF Division of Chemistry: Disciplinary Research Programs  This solicitation applies to nine CHE Disciplinary Chemistry Research Programs: Chemical Catalysis (CAT); Chemical Measurement and Imaging (CMI); Chemical Structure, Dynamics and Mechanisms-A (CSDM-A); Chemical Structure Dynamics and Mechanisms-B (CSDM-B); Chemical Synthesis( SYN); Chemical Theory, Models and Computational Methods (CTMC); Chemistry of Life Processes (CLP); Environmental Chemical Sciences (ECS); and Macromolecular, Supramolecular and Nanochemistry (MSN). All proposals submitted to these nine CHE Disciplinary Research Programs (other than the following exceptions) must be submitted through this solicitation, otherwise they will be returned without review. 

October 1, 2018

NSF Big Ideas updates


DOD-CDMRP Ovarian Cancer Research Program (OCRP)  

Deadlines vary by program area

DOD-CDMRP Lung Cancer


DOD-CDMRP Prostate Cancer 


DOD-CDMRP Peer Reviewed Cancer Research Program


DOD-CDMRP Peer Reviewed Medical Research Program  The program includes several mechanisms including:  Discovery Award; Focused Program Award; Investigator-Initiated Research Award, and Technology/Therapeutic Development Award. 


The AACR is currently accepting applications for the following opportunities:

Grants for mentored researchers in the areas of lung, ovarian, pediatric, and breast cancer research, lymphoma, myeloma, and all areas of clinical and translational cancer research

A grant for tenure-eligible junior faculty focused on any area of cancer research

A grant for established investigators in the field of neuroendocrine tumor research

Learn More

Apply Now


Limited Submissions

Purdue Internal Deadlines for Proposals

Numerous new opportunities, follow link for details





  • Purdue University Center for Cancer Research
    Hansen Life Sciences Research Building
    201 S. University Street
    West Lafayette, IN 47907-2064

  • Phone: (765) 494-9129
    Fax: (765) 494-9193
    Contact us with questions at:

© Copyright 2014 The Purdue University Center for Cancer Research is the first NCI funded Center in Indiana.